icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
ENDURANCE-2: Safety and Efficacy of Glecaprevir/Pibrentasvir in Hepatitis C Virus Genotype 2-infected Patients without Cirrhosis: a Randomized, Double-Blind, Placebo-Controlled Study
 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
Kris V Kowdley1, Massimo Colombo2, Neddie Zadeikis3, Parvez S Mantry4, Filipe Calinas5, Humberto Aguilar6, Victor de Ledinghen7, Yves Horsmans8, Yiran Hu3, Teresa I Ng3, Federico Mensa3

HIV1

HIV2

HIV3

HIV4

HIV5

HIV6

HIV7

HIV8

HIV9